Impact of Nonosseous Findings on 18F-NaF PET/CT in a Patient with Ductal Breast Carcinoma
- 142 Downloads
- 2 Citations
Abstract
18F-NaF was used as a bone-seeking PET tracer for skeletal imaging until the introduction of the widely available 99mTc-labeled bone agents. However, there is renewed clinical interest in 18F-NaF since prior technical and logistic limitations to its routine use are no longer present, and, as a consequence, it is likely that uptake unrelated to bone and non-osseous findings will be encountered more frequently. As a result of tumoral necrosis, soft tissue metastases may demonstrate 18F-NaF avidity due to dystrophic calcification. On the other hand, all non-osseous findings, whether 18F-NaF avid or not, may provide important diagnostic information that may alter the course of the disease, including treatment options. Herein we present a patient with ductal carcinoma of the breast in whom findings unrelated to the skeletal system in 18F-NaF PET/CT altered the treatment strategy.
Keywords
18F-NaF PET/CT 18F-FDG PET/CT Bone metastasis Breast carcinomaNotes
Acknowledgments
All authors declare no conflict of interest.
References
- 1.Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49(1):68–78.PubMedCrossRefGoogle Scholar
- 2.Tateishi U, Morita S, Taguri M, Shizukuishi K, Minamimoto R, Kawaguchi M, et al. A meta-analysis of (18)F-fluoride positron emission tomography for assessment of metastatic bone tumor. Ann Nucl Med. 2010;24(7):523–31.PubMedCrossRefGoogle Scholar
- 3.Nishiyama Y, Tateishi U, Shizukuishi K, Shishikura A, Yamazaki E, Shibata H, et al. Role of 18F-fluoride PET/CT in the assessment of multiple myeloma: initial experience. Ann Nucl Med. 2013;27(1):78–83.PubMedCrossRefGoogle Scholar
- 4.Pirayesh E, Rakhshan A, Amoui M, Rakhsha A, Poor AS, Assadi M. Metastasis of femoral osteosarcoma to the abdominal wall detected on 99mTc-MDP skeletal scintigraphy. Ann Nucl Med. 2013. doi: 10.1007/s12149-013-0708-6.PubMedGoogle Scholar
- 5.Basu S, Kembhavi S. Serendipitous observation of hepatic metastases on (18)F-fluoride PET in a patient with infiltrating ductal carcinoma of breast: correlation with contrast enhanced CT. Clin Nucl Med. 2012;37(12):1176–8.PubMedGoogle Scholar
- 6.Sheth S, Colletti PM. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans. Clin Nucl Med. 2012;37(5):e110–6.PubMedCrossRefGoogle Scholar
- 7.Swiętaszczyk C, Prasad V, Baum RP. Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapy. Clin Nucl Med. 2012;37(4):e82–3.PubMedCrossRefGoogle Scholar
- 8.Stewart VL, Herling P, Dalinka MK. Calcification in soft tissues. JAMA. 1983;250(1):78–81.PubMedCrossRefGoogle Scholar